CompletedPhase 2NCT00244855

Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma

Studying MALT lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fred Hutchinson Cancer Center
Principal Investigator
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Intervention
pharmacological study(other)
Enrollment
32 enrolled
Eligibility
18 years · All sexes
Timeline
2004 – 2011

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00244855 on ClinicalTrials.gov

Other trials for MALT lymphoma

Additional recruiting or active studies for the same condition.

See all trials for MALT lymphoma →

← Back to all trials